esophageal cancer

You have access
The Long-term Outcomes of Borderline Resectable T3 in Locally Advanced Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Triplet Chemotherapy
JUNYA KITADANI, KEIJI HAYATA, TARO GODA, SHINTA TOMINAGA, NAOKI FUKUDA, TOMOKI NAKAI, SHOTARO NAGANO and MANABU KAWAI

Anticancer Research May 2025, 45 (5) 2225-2235; DOI: https://doi.org/10.21873/anticanres.17596
You have access
Negative Impact of High FOXP3 Status in Lymph Nodes of Esophageal Squamous Cell Carcinoma Patients
YUKIKO NONAKA, TAISUKE BABA, SHIZUKI SUGITA, KAZUSHI MIYATA, MASAKI SUNAGAWA, JUNPEI YAMAGUCHI, TOSHIO KOKURYO, YUKIHIRO YOKOYAMA and TOMOKI EBATA

Anticancer Research February 2025, 45 (2) 781-787; DOI: https://doi.org/10.21873/anticanres.17466
Open Access
The Clinical Impact of the Systemic Immune-inflammation Index in Esophageal Cancer Patients Receiving Curative Treatment
RYUKI ESASHI, TORU AOYAMA, YUKIO MAEZAWA, ITARU HASHIMOTO, SOSUKE YAMAMOTO, MAMORU UCHIYAMA, KOJI NUMATA, SHINNOSUKE KAWAHARA, KEISUKE KAZAMA, AYAKO TAMAGAWA, AYA SAITO and NORIO YUKAWA

Anticancer Research November 2024, 44 (11) 5035-5041; DOI: https://doi.org/10.21873/anticanres.17327
You have access
Helicobacter pylori Infection Affects the Tumor Immune Microenvironment of Esophageal Cancer Patients
HIROKI MATSUDA, KOTA IWAHORI, TOMOHIRA TAKEOKA, RYO KATO, SHINYA URAKAWA, TAKURO SAITO, TOMOKI MAKINO, HIDETOSHI EGUCHI, YUICHIRO DOKI and HISASHI WADA

Anticancer Research September 2024, 44 (9) 3799-3805; DOI: https://doi.org/10.21873/anticanres.17205
Open Access
[¹¹C]Methionine PET vs. [¹⁸F]Fluorodeoxyglucose PET Whole-body Imaging to Determine the Extent of Methionine-addiction Compared to Glucose-addiction of Primary and Metastatic Cancer of the Trunk in Patients
MOTOKAZU SATO, TOSHIHIKO SATO, CHIHIRO HOZUMI, QINGHONG HAN, KOHEI MIZUTA, SEI MORINAGA, BYUNG MO KANG, NORITOSHI KOBAYASHI, YASUSHI ICHIKAWA, ATSUSHI NAKAJIMA and ROBERT M. HOFFMAN

Anticancer Research September 2024, 44 (9) 3891-3898; DOI: https://doi.org/10.21873/anticanres.17216
Open Access
Maximum Efficacy of Immune Checkpoint Inhibitors Occurs in Esophageal Cancer Patients With a Low Neutrophil-to-Lymphocyte Ratio and Good Performance Status Prior to Treatment
YUYA HIRASAWA, YUTARO KUBOTA, EMIKO MURA, RISAKO SUZUKI, TOSHIAKI TSURUI, NANA IRIGUCHI, TOMOYUKI ISHIGURO, RYOTARO OHKUMA, MASAHIRO SHIMOKAWA, HIROTSUGU ARIIZUMI, ATSUSHI HORIIKE, SATOSHI WADA, TOMOTAKE ARIYOSHI, SATORU GOTO, KOJI OTSUKA, MASAHIKO MURAKAMI, YUJI KIUCHI, KIYOSHI YOSHIMURA, ROBERT M. HOFFMAN and TAKUYA TSUNODA

Anticancer Research August 2024, 44 (8) 3397-3407; DOI: https://doi.org/10.21873/anticanres.17160
You have access
The Prognostic Immune and Nutritional Indices Are Independent Prognostic Factors for Esophageal Cancer Patients Who Receive Curative Treatment
TORU AOYAMA, ITARU HASHIMOTO, YUKIO MAEZAWA, KENTARO HARA, AYA KATO, KEISUKE KAZAMA, AYAKO TAMAGAWA, HARUHIKO CHO, MASATO NAKAZONO, MASAKATSU NUMATA, SHINNOSUKE KAWAHARA, TAKASHI OSHIMA, AYA SAITO and NORIO YUKAWA

Anticancer Research May 2024, 44 (5) 2185-2192; DOI: https://doi.org/10.21873/anticanres.17025
You have access
Impact of Arteriosclerosis on Reconstruction-related Complications After Esophagectomy and Usefulness of Tailor-made Reconstruction Technique
TAKAHISA YAMAGUCHI, KOICHI OKAMOTO, HIROTO SAITO, MARI SHIMADA, TOSHIKATSU TSUJI, HIDEKI MORIYAMA, JUN KINOSHITA, ITASU NINOMIYA and NORIYUKI INAKI

Anticancer Research April 2024, 44 (4) 1719-1726; DOI: https://doi.org/10.21873/anticanres.16971
You have access
Effectiveness of Combination Chemotherapy With Docetaxel, Nedaplatin, and 5-Fluorouracil for Advanced and Recurrent Esophageal Cancer
MAKOTO SOHDA, KEIGO HARA, KENGO KURIYAMA, KOUHEI TATENO, SHINTARO UCHIDA, TAKAYOSHI WATANABE, YUTA SHIBASAKI, HIDEYUKI SAITO, NOBUHIRO NAKAZAWA, AKIHIKO SANO, MAKOTO SAKAI, TAKEHIKO YOKOBORI, HIROOMI OGAWA, KEN SHIRABE and HIROSHI SAEKI

Anticancer Research March 2024, 44 (3) 1309-1315; DOI: https://doi.org/10.21873/anticanres.16926
You have access
CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for the Esophageal Cancer Patients Who Received Curative Treatment
TORU AOYAMA, ITARU HASHIMOTO, YUKIO MAEZAWA, KENTARO HARA, KEISUKE KAZAMA, KEISUKE KOMORI, MASAKATSU NUMATA, AYAKO TAMAGAWA, MOMOKO FUKUDA, HARUHIKO CHO, JUNYA MORITA, SUZUE YOSHIZAWA, KAZUKI OTANI, AYA KATO, MIE TANABE, MASATO NAKAZONO, SHINNOSUKE KAWAHARA, TAKASHI OSHIMA, AYA SAITO, NORIO YUKAWA and YASUSHI RINO

Anticancer Research February 2024, 44 (2) 815-822; DOI: https://doi.org/10.21873/anticanres.16873

Main menu

User menu

Search

esophageal cancer

Pages